In patients with RA, the mean frequency of CD19+CD95+ on B cells was 12.7 ± 0.6% (mean ± SEM) when compared with 6.3 ± 0.4% in HD (p < 0.0001). The gene discussed is CD19; the disease is rheumatoid arthritis.